Innovative immunological strategies for type 1 diabetes.
Servei d'Immunologia, Institut de Recerca Germans Trias i Pujol, Badalona, Barcelona, España; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, España. Electronic address: mvives@igtp.cat.
Marta
M
Vives-Pi
Servei d'Immunologia, Institut de Recerca Germans Trias i Pujol, Badalona, Barcelona, España.
Irma
I
Pujol-Autonell
D064987:Cell- and Tissue-Based Therapy / Q000379:methods* / Q000639:trends; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D036103:Nanotechnology; D035703:Therapies, Investigational